Tonix Pharmaceuticals (NASDAQ:TNXP) announced the appointment of Ganesh Kamath as its head of market access, effective September 29, 2025.
The biotechnology company said Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix.
Zacatecas Silver Corp. (TSX-V:ZAC, OTC:ZCTSF) announced the closing of its over-subscribed, non-brokered private placement financing of 62.5 million company units, at a price of C$0.06 per unit, for total gross proceeds of C$3.75 million.
The precious metals projects developer said the financing was previously upsized from C$2.5 million to C$3.75 million in order to include a strategic order from a highly regarded global mining investment fund, underscoring confidence in the company’s high-grade silver and gold portfolio in Mexico.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said Tuesday it has been invited to present at a major biotechnology conference in Riyadh, underscoring Saudi Arabia’s push to position itself as a global hub for life sciences research and investment.
The Nasdaq-listed biotech will attend the Life Science Innovation Forum, a two-day event hosted Oct. 1–2 at the King Saud bin Abdulaziz University for Health Sciences Conference Center. The meeting is backed by J.P. Morgan Asset Management in collaboration with the King Abdullah International Medical Research Center.
Sonoro Gold Corp (TSX-V:SGO, OTCQB:SMOFF) said Tuesday it plans to update a key economic study for its flagship Cerro Caliche gold project in Mexico while also weighing a possible spinout of a second property into a new company.
The Toronto-listed miner intends to commission a revised Preliminary Economic Assessment, or PEA, for Cerro Caliche, an open-pit, heap-leach gold project in Sonora state.
C3 Metals Inc (TSX-V:CCCM, OTC:CARCF) has launched its first-ever drill program at the Khaleesi copper-gold project in southern Peru, marking a milestone for the explorer as it tests a promising stretch of the country’s well-known Andahuaylas-Yauri mineral belt.
The company said Tuesday that the maiden campaign will include 14 diamond drill holes totalling 6,300 metres. Two rigs are being deployed: one focused on skarn-style copper-gold mineralisation and the other targeting porphyry copper.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) announced it has signed a binding letter of intent (LOI) to acquire Eventdex, a registration and badge-printing software company.
The AI-powered event management company said the purchase price for Eventdex is about $700,000, payable entirely in cash subject to customary adjustments.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) has confirmed that full development of its Tulu Kapi Gold Project in Ethiopia remains on schedule to begin in October 2025.
"Significant progress was made in the period and KEFI is on schedule to begin the full development program of Tulu Kapi ... We have approved and expect to sign shortly the formal commitment of the project loan facilities," executive chair Harry Anagnostaras-Adams said in Tuesday's interim results statement.
Falcon Oil & Gas Ltd (AIM:FOG, TSX-V:FO) shares traded higher after it agreed to be bought out by exploration partner Tamboran Resources Corporation (ASX:TBN, NYSE:TBN, OTC:TBNRL) for £128 million (C$239.00 million), mostly in shares plus US$23.7 million in cash.
It comes as the Beetaloo project in Australia is again advancing, and after the capital 'carry' that Falcon previously secured via farm-out had been spent. The AIM-quoted firm has self-funded its participation in the project since mid-2024.
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) reported interim results today as a renewed, realigned and reinvigorated company, with many of the key changes occurring in the period that followed the first half.
"The introduction of new leadership, and the injection of fresh capital have realigned Active Energy Group's strategy and set a clear path forward," said chief executive Paul Elliot.
Futura Medical PLC's (AIM:FUM, OTC:FAMDF) new chief executive has said he is taking a patient and careful approach to a strategic review of the business, stressing there is significant value in its two key assets, Eroxon Intense and WSD4000.
Alex Duggan, who stepped up as interim CEO in September, said: “Since my appointment as interim CEO, I have been working closely with the Board and the wider team to carefully review the business, its priorities, and its strategic options.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) has said it expects 2026 to be a decisive year as it pushes forward its gene therapy programmes in both human and animal health.
The company, which is developing treatments based on SIRT6, a gene linked to healthy ageing, said it is moving closer to clinical trials in advanced stages of metabolic liver disease and progressing new work in eye disorders.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) is expecting substantial progress in key areas in the coming months, as the Paradox project in Utah advances toward development.
Specifically, Zephyr is working to secure gas sales and export arrangements, as well as advanced talks to potential partners to enable an accelerated drill programme, to step up the number of wells at Paradox.
Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has secured shareholder approval for an ASX waiver to issue new securities without further shareholder votes, while also updating the market on the timeline for its pivotal PARADIGM trial of the DurAVR® Transcatheter Heart Valve (THV).
At a special meeting held on September 29, around 51.8% of Anteris’ outstanding shares were represented, with stockholders voting strongly in favour of the waiver proposal. The measure passed with more than 13.6 million votes in support against 2.6 million opposed, while a secondary adjournment proposal also cleared comfortably, though ultimately no adjournment was needed.
Riversgold Ltd (ASX:RGL, OTC:RVSGF) has struck a Right to Mine and Co-Operation Agreement with MEGA Resources that will see the Kalgoorlie-based mining services provider fully fund development and operations at the Northern Zone Gold Project in Western Australia.
The deal gives MEGA the right to mine at Northern Zone, with profits split 50/50 between MEGA and the project owners — Riversgold (80%) and Oracle Power PLC (AIM:ORCP) (20%). Importantly, Riversgold and Oracle will not be required to contribute any up-front capital.
Tamboran Resources Corporation (ASX:TBN, NYSE:TBN, OTC:TBNRL) has secured a major milestone with its Beetaloo Joint Venture (BJV) approving a Final Investment Decision (FID) for the Shenandoah South Pilot Project, setting the stage for first gas sales from mid-2026.
The decision follows a string of key approvals and agreements, including deals with Native Title Holders, the Northern Land Council and the Northern Territory Government under the Beneficial Use of Gas legislation. Tamboran has also locked in a Gas Sales Agreement with the NT Government to supply 40 terajoules per day (TJ/d) at a fixed, Consumer Price Index-linked price.
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has ticked off several milestones for its lead oncology asset HMBD-002, laying the groundwork for a Phase II clinical trial in 2026.
The Melbourne-based biotech said the technology transfer of HMBD-002 from Singapore’s Hummingbird Bioscience was now largely complete, with Percheron now taking possession of all relevant data and existing drug supplies. The Investigational New Drug (IND) application with the US Food and Drug Administration has also shifted from Hummingbird to Percheron, making the company formally responsible for the program’s future development.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has strengthened the international rollout of its flagship nerve repair device Remplir™, appointing its first Canadian distributor ahead of a formal launch at the Annual Meeting of the American Society for Surgery of the Hand (ASSH) in Vancouver this October.
The agreement secures exclusive distributorships for Alberta and British Columbia, with additional appointments planned to ensure nationwide coverage of the US$75 million Canadian nerve repair market. First Canadian sales are expected in the December quarter, with uptake forecast to build into 2026.
Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has elected to adopt an owner-operator mining model at its flagship Kangankunde Rare Earths Project in Malawi, a move it says will deliver tighter operational control and significant cost savings while accelerating the start of mining.
Following a structured review of five contractor proposals, Lindian determined that self-performing mining activities would provide stronger oversight of scheduling, costs, quality, human resources and safety. Mining execution costs are now expected to fall about 30% to roughly US$8.40 per tonne, down from the US$12 per tonne assumed in the Stage 1 Feasibility Study (FS).
Altech Batteries Ltd (ASX:ATC, OTC:ALTHF) has struck a strategic collaboration agreement with China’s AMPower, a subsidiary of battery giant Chilwee Group, to begin selling sodium nickel chloride (Na/NiCl₂) batteries across Australia, Europe and the United States.
The move delivers Altech an immediate commercial presence in the fast-growing energy storage market, ahead of commissioning its flagship 120-megawatt-hour (MWh) CERENERGY® project in Germany.